CIS Insulin Market (2024 - 2030) Size, Share & Trends Analysis Report By Product, By Type (Human Insulin, Insulin Analog), By Application (Type 1 Diabetes), By Distribution Channel, By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
- Buy Now
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. CIS Insulin Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. CIS Insulin Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. CIS Insulin Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. CIS Insulin Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Rapid-acting Insulin
4.3.1. Rapid-acting Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Long-acting Insulin
4.4.1. Long-acting Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Combination Insulin
4.5.1. Combination Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Biosimilar
4.6.1. Biosimilar Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Other Products
4.7.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. CIS Insulin Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. CIS Insulin Market: Type Movement Analysis, USD Million, 2023 & 2030
5.3. Human Insulin
5.3.1. Human Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Insulin Analog
5.4.1. Insulin Analog Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. CIS Insulin Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. CIS Insulin Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Type I Diabetes
6.3.1. Type I Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Type II Diabetes
6.4.1. Type II Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. CIS Insulin Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. CIS Insulin Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
7.3. Hospital Pharmacies
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Retail & Specialty Pharmacies
7.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Other Distribution Channels
7.5.1. Other Distribution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. CIS Insulin Market: Regional Estimates & Trend Analysis
8.1. CIS Insulin Market Share, By Region, 2023 & 2030, USD Million
8.2. Commonwealth of Independent States (CIS)
8.2.1. CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. Russia
8.2.2.1. Russia CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Poland
8.2.3.1. Poland CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Turkey
8.2.4.1. Turkey CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.5. Ukraine
8.2.5.1. Ukraine CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.6. Uzbekistan
8.2.6.1. Uzbekistan CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.7. Belarus
8.2.7.1. Belarus CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.8. Kazakhstan
8.2.8.1. Kazakhstan CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.9. Rest of CIS
8.2.9.1. Rest of CIS Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Eli Lilly and Company
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. Sanofi S.A.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. Boehringer Ingelheim International GmbH
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. Oramed Pharmaceuticals Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. Novo Nordisk A/S
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Merck & Co., Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. Bristol-Myers Squibb Company
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives
9.4.8. Novartis AG
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/Strategic Initiatives
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
